Exploration
Accueil
Racine
Exploration
Accueil

Corpus GrippeCanadaV3

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Past exposure to vaccines and subsequent risk of Alzheimer's disease.

Identifieur interne : 000990 ( Main/Exploration ); précédent : 000989; suivant : 000991

Past exposure to vaccines and subsequent risk of Alzheimer's disease.

Auteurs : R. Verreault [Canada] ; D. Laurin ; J. Lindsay ; G. De Serres

Source :

RBID : pubmed:11762573

Descripteurs français

English descriptors

Abstract

BACKGROUND

It has been suggested that changes to the immune system could be a factor in age-related conditions such as Alzheimer's disease. Our objective was to examine the association between past exposure to conventional vaccines and risk of Alzheimer's disease.

METHODS

We analyzed data from a representative community sample of subjects 65 years of age or older participating in the Canadian Study of Health and Aging, a prospective cohort study of dementia. Screening and clinical evaluations were done at both baseline and follow-up. Past exposure to vaccines was assessed at baseline by means of a self-administered questionnaire.

RESULTS

Of the 4392 eligible subjects who were cognitively unimpaired and for whom vaccine information was available at baseline (in 1991-1992) and who completed follow-up 5 years later (in 1996-1997), 527 were diagnosed as having cognitive impairment or dementia other than Alzheimer's disease and were excluded from these analyses. Of the remaining subjects, 3682 were cognitively unimpaired at follow-up and 183 were newly diagnosed as having Alzheimer's disease. After adjustment for age, sex and education, past exposure to vaccines against diphtheria or tetanus, poliomyelitis and influenza was associated with lower risk for Alzheimer's disease (odds ratio [OR] 0.41, 95% confidence interval [CI] 0.27-0.62; OR 0.60, 95% CI 0.37-0.99; and OR 0.75, 95% CI 0.54-1.04 respectively) than no exposure to these vaccines.

INTERPRETATION

Past exposure to vaccines against diphtheria or tetanus, poliomyelitis and influenza may protect against subsequent development of Alzheimer's disease.


PubMed: 11762573


Affiliations:

Links toward previous steps (curation, corpus...)

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Past exposure to vaccines and subsequent risk of Alzheimer's disease.</title>
<author>
<name sortKey="Verreault, R" sort="Verreault, R" uniqKey="Verreault R" first="R" last="Verreault">R. Verreault</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laval University Geriatric Research Unit, Centre d'hébergement Saint-Augustin du Centre hospitalier affilié universitaire de Quebec, Beauport. Rene.Verreault@msp.ulaval.ca</nlm:affiliation>
<country wicri:rule="url">Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Laurin, D" sort="Laurin, D" uniqKey="Laurin D" first="D" last="Laurin">D. Laurin</name>
</author>
<author>
<name sortKey="Lindsay, J" sort="Lindsay, J" uniqKey="Lindsay J" first="J" last="Lindsay">J. Lindsay</name>
</author>
<author>
<name sortKey="De Serres, G" sort="De Serres, G" uniqKey="De Serres G" first="G" last="De Serres">G. De Serres</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2001">2001</date>
<idno type="RBID">pubmed:11762573</idno>
<idno type="pmid">11762573</idno>
<idno type="wicri:Area/Main/Corpus">000A63</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000A63</idno>
<idno type="wicri:Area/Main/Curation">000A63</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000A63</idno>
<idno type="wicri:Area/Main/Exploration">000A63</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Past exposure to vaccines and subsequent risk of Alzheimer's disease.</title>
<author>
<name sortKey="Verreault, R" sort="Verreault, R" uniqKey="Verreault R" first="R" last="Verreault">R. Verreault</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laval University Geriatric Research Unit, Centre d'hébergement Saint-Augustin du Centre hospitalier affilié universitaire de Quebec, Beauport. Rene.Verreault@msp.ulaval.ca</nlm:affiliation>
<country wicri:rule="url">Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Laurin, D" sort="Laurin, D" uniqKey="Laurin D" first="D" last="Laurin">D. Laurin</name>
</author>
<author>
<name sortKey="Lindsay, J" sort="Lindsay, J" uniqKey="Lindsay J" first="J" last="Lindsay">J. Lindsay</name>
</author>
<author>
<name sortKey="De Serres, G" sort="De Serres, G" uniqKey="De Serres G" first="G" last="De Serres">G. De Serres</name>
</author>
</analytic>
<series>
<title level="j">CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</title>
<idno type="ISSN">0820-3946</idno>
<imprint>
<date when="2001" type="published">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Age Distribution</term>
<term>Age Factors</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Alzheimer Disease (diagnosis)</term>
<term>Alzheimer Disease (epidemiology)</term>
<term>Alzheimer Disease (etiology)</term>
<term>Alzheimer Disease (prevention & control)</term>
<term>Canada (epidemiology)</term>
<term>Diphtheria Toxoid (immunology)</term>
<term>Female</term>
<term>Humans</term>
<term>Influenza Vaccines (immunology)</term>
<term>Male</term>
<term>Mass Screening</term>
<term>Middle Aged</term>
<term>Poliovirus Vaccines (immunology)</term>
<term>Prospective Studies</term>
<term>Regression Analysis</term>
<term>Risk Factors</term>
<term>Sex Distribution</term>
<term>Tetanus Toxoid (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte d'âge moyen</term>
<term>Analyse de régression</term>
<term>Anatoxine diphtérique (immunologie)</term>
<term>Anatoxine tétanique (immunologie)</term>
<term>Canada (épidémiologie)</term>
<term>Dépistage systématique</term>
<term>Facteurs de l'âge</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Maladie d'Alzheimer ()</term>
<term>Maladie d'Alzheimer (diagnostic)</term>
<term>Maladie d'Alzheimer (épidémiologie)</term>
<term>Maladie d'Alzheimer (étiologie)</term>
<term>Mâle</term>
<term>Répartition par sexe</term>
<term>Répartition par âge</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Vaccins antigrippaux (immunologie)</term>
<term>Vaccins antipoliomyélitiques (immunologie)</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Diphtheria Toxoid</term>
<term>Influenza Vaccines</term>
<term>Poliovirus Vaccines</term>
<term>Tetanus Toxoid</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Canada</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Alzheimer Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Maladie d'Alzheimer</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Alzheimer Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Alzheimer Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Anatoxine diphtérique</term>
<term>Anatoxine tétanique</term>
<term>Vaccins antigrippaux</term>
<term>Vaccins antipoliomyélitiques</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Alzheimer Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Canada</term>
<term>Maladie d'Alzheimer</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Maladie d'Alzheimer</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Age Distribution</term>
<term>Age Factors</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Mass Screening</term>
<term>Middle Aged</term>
<term>Prospective Studies</term>
<term>Regression Analysis</term>
<term>Risk Factors</term>
<term>Sex Distribution</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte d'âge moyen</term>
<term>Analyse de régression</term>
<term>Dépistage systématique</term>
<term>Facteurs de l'âge</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Maladie d'Alzheimer</term>
<term>Mâle</term>
<term>Répartition par sexe</term>
<term>Répartition par âge</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Canada</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>BACKGROUND</b>
</p>
<p>It has been suggested that changes to the immune system could be a factor in age-related conditions such as Alzheimer's disease. Our objective was to examine the association between past exposure to conventional vaccines and risk of Alzheimer's disease.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>METHODS</b>
</p>
<p>We analyzed data from a representative community sample of subjects 65 years of age or older participating in the Canadian Study of Health and Aging, a prospective cohort study of dementia. Screening and clinical evaluations were done at both baseline and follow-up. Past exposure to vaccines was assessed at baseline by means of a self-administered questionnaire.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>RESULTS</b>
</p>
<p>Of the 4392 eligible subjects who were cognitively unimpaired and for whom vaccine information was available at baseline (in 1991-1992) and who completed follow-up 5 years later (in 1996-1997), 527 were diagnosed as having cognitive impairment or dementia other than Alzheimer's disease and were excluded from these analyses. Of the remaining subjects, 3682 were cognitively unimpaired at follow-up and 183 were newly diagnosed as having Alzheimer's disease. After adjustment for age, sex and education, past exposure to vaccines against diphtheria or tetanus, poliomyelitis and influenza was associated with lower risk for Alzheimer's disease (odds ratio [OR] 0.41, 95% confidence interval [CI] 0.27-0.62; OR 0.60, 95% CI 0.37-0.99; and OR 0.75, 95% CI 0.54-1.04 respectively) than no exposure to these vaccines.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>INTERPRETATION</b>
</p>
<p>Past exposure to vaccines against diphtheria or tetanus, poliomyelitis and influenza may protect against subsequent development of Alzheimer's disease.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">11762573</PMID>
<DateCompleted>
<Year>2001</Year>
<Month>12</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0820-3946</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>165</Volume>
<Issue>11</Issue>
<PubDate>
<Year>2001</Year>
<Month>Nov</Month>
<Day>27</Day>
</PubDate>
</JournalIssue>
<Title>CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</Title>
<ISOAbbreviation>CMAJ</ISOAbbreviation>
</Journal>
<ArticleTitle>Past exposure to vaccines and subsequent risk of Alzheimer's disease.</ArticleTitle>
<Pagination>
<MedlinePgn>1495-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">It has been suggested that changes to the immune system could be a factor in age-related conditions such as Alzheimer's disease. Our objective was to examine the association between past exposure to conventional vaccines and risk of Alzheimer's disease.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We analyzed data from a representative community sample of subjects 65 years of age or older participating in the Canadian Study of Health and Aging, a prospective cohort study of dementia. Screening and clinical evaluations were done at both baseline and follow-up. Past exposure to vaccines was assessed at baseline by means of a self-administered questionnaire.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 4392 eligible subjects who were cognitively unimpaired and for whom vaccine information was available at baseline (in 1991-1992) and who completed follow-up 5 years later (in 1996-1997), 527 were diagnosed as having cognitive impairment or dementia other than Alzheimer's disease and were excluded from these analyses. Of the remaining subjects, 3682 were cognitively unimpaired at follow-up and 183 were newly diagnosed as having Alzheimer's disease. After adjustment for age, sex and education, past exposure to vaccines against diphtheria or tetanus, poliomyelitis and influenza was associated with lower risk for Alzheimer's disease (odds ratio [OR] 0.41, 95% confidence interval [CI] 0.27-0.62; OR 0.60, 95% CI 0.37-0.99; and OR 0.75, 95% CI 0.54-1.04 respectively) than no exposure to these vaccines.</AbstractText>
<AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Past exposure to vaccines against diphtheria or tetanus, poliomyelitis and influenza may protect against subsequent development of Alzheimer's disease.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Verreault</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Laval University Geriatric Research Unit, Centre d'hébergement Saint-Augustin du Centre hospitalier affilié universitaire de Quebec, Beauport. Rene.Verreault@msp.ulaval.ca</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Laurin</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lindsay</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>De Serres</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Canada</Country>
<MedlineTA>CMAJ</MedlineTA>
<NlmUniqueID>9711805</NlmUniqueID>
<ISSNLinking>0820-3946</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004168">Diphtheria Toxoid</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D023321">Poliovirus Vaccines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013745">Tetanus Toxoid</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>CMAJ. 2002 Jul 9;167(1):13</RefSource>
<PMID Version="1">12137067</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004168" MajorTopicYN="N">Diphtheria Toxoid</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008403" MajorTopicYN="N">Mass Screening</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D023321" MajorTopicYN="N">Poliovirus Vaccines</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017678" MajorTopicYN="N">Sex Distribution</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013745" MajorTopicYN="N">Tetanus Toxoid</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2002</Year>
<Month>1</Month>
<Day>5</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2002</Year>
<Month>1</Month>
<Day>5</Day>
<Hour>10</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2002</Year>
<Month>1</Month>
<Day>5</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">11762573</ArticleId>
<ArticleId IdType="pmc">PMC81665</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Neurology. 1984 Jul;34(7):939-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6610841</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurology. 2000 Jul 12;55(1):66-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10891908</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Med Hypotheses. 2001 Jan;56(1):124-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11133269</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Electrophoresis. 2001 Feb;22(3):445-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11258753</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Novartis Found Symp. 2001;235:130-9; discussion 139-45, 146-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11280023</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychiatry Res. 1999 Jan 18;85(1):71-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10195318</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Psychiatry. 1987 Aug;48(8):314-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3611032</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Age Ageing. 1987 Sep;16(5):311-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3687571</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>CMAJ. 1994 Mar 15;150(6):899-913</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8131123</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurodegeneration. 1995 Mar;4(1):107-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7600179</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="De Serres, G" sort="De Serres, G" uniqKey="De Serres G" first="G" last="De Serres">G. De Serres</name>
<name sortKey="Laurin, D" sort="Laurin, D" uniqKey="Laurin D" first="D" last="Laurin">D. Laurin</name>
<name sortKey="Lindsay, J" sort="Lindsay, J" uniqKey="Lindsay J" first="J" last="Lindsay">J. Lindsay</name>
</noCountry>
<country name="Canada">
<noRegion>
<name sortKey="Verreault, R" sort="Verreault, R" uniqKey="Verreault R" first="R" last="Verreault">R. Verreault</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000990 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000990 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeCanadaV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:11762573
   |texte=   Past exposure to vaccines and subsequent risk of Alzheimer's disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:11762573" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeCanadaV3
Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Tue Jul 7 13:36:58 2020. Site generation: Sat Sep 26 07:06:42 2020